As private equity firms reportedly place their bids, Sanofi may soon follow in the footsteps of GSK and Johnson & Johnson with the separation of its consumer health unit. | Sanofi has received two private equity offers for its consumer health business,

French pharma giant Sanofi received binding offers for its consumer health business from private equity firms PAI Partners and Clayton Dubilier & Rice, with expectations that a deal would be worth at least €15 billion,

Sanofi has received binding offers for its consumer health division from private equity firms Clayton Dubilier & Rice and PAI Partners, as the French drugmaker inches closer to one of the largest European deals this year,

Sanofi has received two separate bids for its consumer health unit, which could be valued at 15 billion euros ($16.74 billion) or more, from private equity firms Clayton Dubilier & Rice and PAI Partners,

BANKS and other lenders are lining up more than 10 billion euros (S$14.3 billion) of debt to back a buyout of Sanofi’s consumer health division, as one of the most highly anticipated sales of the year reaches its final stages.

Sanofi (SNY) has won bindings bids for its consumer health division from private equity firms CD&R and PAI Partners. Read more here.